알레르기 비염엔 알레그라알레르기 비염엔 알레그라 Facebook ad: “알레르기 비염을 피하는 방법은?”
Ran for 12 days, from March 19 to March 31, 2026, the last day Crush saw it.
Run by 알레르기 비염엔 알레그라 on Instagram. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1556656788779628
- Platforms
- Relaunches
- 0
Ad text
✅ 알레르기 비염을 피하는 방법은? 자주 자주 청소하기🧹✨ 하지만 이미 시작됐다면, 😴 졸음 걱정 줄이고⁸ 💨 1시간 이내 빠른 효과 발현과¹⁰ ⏱ 최대 24시간 지속되는⁹ 3세대 항히스타민제 알레그라와 함께¹¯⁴ 알레르기 비염 증상을 완화해보세요! #알레르기_비염엔_알레그라⁵¯⁷ #알레르기비염 #allegra [광고심의필] 2026-1796-001907 MAT-KR-2600203-v1.0-03/2026 부작용이 있을 수 있으니 첨부된 '사용상의 주의사항'을 잘 읽고, 의사·약사와 상의하세요. [판매사] 오펠라헬스케어코리아㈜ [제조사] ㈜한독 [제품명] 알레그라 정 120mg [References] 1. Mark E et al. Efficacy and tolerability of 2nd and 3rdgenantihistamines. ANNALS OF ALLERGY, ASTHMA &IMMUNOL.2010.104;518–522 2. Fein MN et al. CSACI position statement_Newer generation H1- antihistamines (3rd generation) are safer than first-generation H1- antihistamines. Allergy Asthma Clin Immunol. 2019.15(61);1-6 3. Anne K et al. Second-and third- generationantihistamines.DERMATOLOGIC THERAPY. 2000.13;327– 336. 4. Thomas B et al. Next generation antihistamines :therapeuticrationale, accomplishments and advances. Expert OpiniononInvestigational Drugs. 2002.11(6);807-817. 5. Brożek JL et al. Allergic Rhinitis and its Impact on Asthma(ARIA)guidelines-2016 revision. J ALLERGY CLIN IMMUNOL.2017.140(4),950-958 6. Van Cauwenberge et al. Comparison of the efficacy, safetyandquality of life provided by fexofenadine hydrochloride 120 mg. ClinExpAllergy. 2000.30(6);891-899 7. T B Casale et al. Safety and Efficacy of Once-Daily FexofenadineHCIin the treatment of autumn seasonal allergic rhinitis. Allergyand AstmaProc. 1999;20(3) 193-8. 8. Smith SM et al. Fexofenadine: biochemical, pharmacokineticandpharmacodynamic properties and its unique role in allergicdisorders.Expert Opinion on Drug Metabolism & Toxicology.2009;5(7);813-822. 9. Peter H et al. Double-blind, placebo-controlled study. Comparingtheefficacy and safety of fexofenadine and cetirizine in seasonal AR.JALLERGY CLIN IMMUNOL. 1999;104(5);927-33 10. Day J H et al. Onset of action, efficacy, and safety of a single doseoffexofenadine hydrochloride. Ann Allergy AsthmaImmunol.1997.79;533-540.
